Open AccessEPIDs and QA of advanced treatments
Author(s) -
Ben J. Mijnheer
Publication year - 2019
Publication title -
journal of physics. conference series
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 85
eISSN - 1742-6596
pISSN - 1742-6588
DOI - 10.1088/1742-6596/1305/1/012061
Subject(s) - medical physics , medicine , nuclear medicine , dosimetry
In this paper I will summarize the various possibilities of EPIDs for their use as tools for QA of advanced treatments. After elucidating the choice of EPIDs for this purpose, I will review the use of EPIDs for pre-treatment and in vivo (transit) dosimetry applications. Several solutions became recently commercially available, allowing relative and/or absolute dose verification at points (0D), in 2D, or in 3D. Each of these solutions will be briefly discussed, indicating the differences in possibilities with respect to QA of advanced treatments. I will conclude with some general remarks about the current status of EPID-based QA of advanced treatments and revealing some future developments in 3D pre-treatment and in vivo dosimetry using EPIDs.